ALR Technologies SG Ltd
alrt.comWhat Do They Do?
Develops diabetes-management software and glucose-monitoring products for healthcare providers, patients and veterinary clinics.
20-F for FY2025, filed Apr 30, 2026We are a data management company that developed a comprehensive approach to diabetes care that includes: (i) an FDA-cleared and…View ↗
Our Diabetes Solution product is a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant diabetes…View ↗
We are focusing our efforts on introducing and marketing our GluCurve products to veterinary clinics, animal health companies, distributors…View ↗
We are focusing our efforts on introducing and marketing our Diabetes Solution product to medical clinics, hospitals, HCPs, and…View ↗
How Do They Make Money?
The company sells GluCurve Pet CGM units to distributors and bills them when the units are delivered.
20-F for FY2025, filed Apr 30, 2026The Company’s revenues in 2023 were from the sale of GluCurve Pet CGM units sold to its distributors. On November 23, 2022, the Company…View ↗
$25.5K
-
20-F for FY2025, filed Apr 30, 2026
$25.5K ↗
Who Are Their Customers?
For GluCurve, it targets veterinary clinics and animal-health businesses; for Diabetes Solution, it targets healthcare providers and pharmaceutical companies. Sales are described through distributors and partners' networks, with a planned direct-to-veterinarian channel in Canada.
20-F for FY2025, filed Apr 30, 2026We are focusing our efforts on introducing and marketing our GluCurve products to veterinary clinics, animal health companies, distributors…View ↗
In December 2022 we entered into a distribution agreement with Covetrus for the distribution of the GluCurve Pet CGM product in Europe…View ↗
We are focusing our efforts on introducing and marketing our Diabetes Solution product to medical clinics, hospitals, HCPs, and…View ↗
We have achieved collaborations with entities in Singapore and are targeting organizations with global operations in order to work with…View ↗
In 2023 the Company launched the website www.glucurve.ca as part of its future plans to provide a direct to veterinarian clinic sales model…View ↗
Do Revenues Turn Into Profits?
No. It lost $7.5M in FY2023.
20-F for FY2025, filed Apr 30, 2026
How Are They Changing?
GluCurve sales channels
The older report described Covetrus as having exclusive rights to sell GluCurve Pet CGM; the latest says that agreement expired and outlines a planned direct-to-veterinarian sales model in Canada while the parties discuss a new agreement.
20-F for FY2022, filed May 1, 2023 20-F for FY2025, filed Apr 30, 2026On November 23, 2022, we entered into a co-branded products distribution agreement with Covetrus, Inc. (“Covetrus”), a global leader in…View ↗
Who Do They Compete With?
Competes with Livongo, Glooko, WellDoc, Medtronic, iGlucose, and Microsoft HealthVault
20-F for FY2025, filed Apr 30, 2026A few companies currently offer human compliance monitoring systems for diabetes, but either (i) at much higher prices; (ii) have fewer…View ↗
Loading...
